#USA #Toronto #Sample Management #Resonant Solutions #Biobank Services

Resonant Clinical Solutions' New Asset Management Programs

In an era where precision and efficiency are pivotal in clinical research, Resonant Clinical Solutions has taken a pioneering step by introducing a suite of asset management programs designed specifically for the biobank industry. These programs, namely Remote Asset Management (RAM), Proactive Asset Management (PAM), and Strategic Asset Management (SAM), were unveiled at the ISBER 2026 International Biospecimen Summit in Toronto, showcasing Resonant's commitment to optimizing sample management strategies in clinical trials.

The launch comes at a crucial time when biological samples are more plentiful than ever before, spread across an increasing number of sites, contract research organizations (CROs), and suppliers. The growing complexity of clinical programs, particularly with advancements in cellular and gene therapies, has amplified the need for robust strategies to ensure sample integrity, traceability, and compliance with ever-evolving audit requirements. Additional pressures on laboratory space and storage budgets further underscore the critical nature of effective sample management decisions.

The Importance of Sample Management

As noted by Christophe Berthoux, CEO of Resonant Clinical Solutions, "Research samples represent years of investment and, in many instances, irreplaceable science. Yet, decisions regarding these samples are often made by default rather than informed choice." This insight drives the essence of the new suite, aiming to provide structured, informed pathways for managing these valuable assets.

Recognizing that each client's needs vary, the Asset Management Programs initiate with a comprehensive assessment of the client’s sample inventory and specific requirements, offering tailored solutions for different scenarios:

• - Remote Asset Management (RAM) caters to organizations holding samples in-house that occupy critical lab space and personnel time. Resonant deploys biobanking specialists onsite to evaluate current inventory practices, manage sample assets in compliance with regulatory requirements, and assist in relocating samples to Resonant's secure biobanking facilities as needed. Key capabilities of RAM include:

- Digitized cataloguing and real-time inventory tracking, providing full visibility and optimizing operations.
- Rapid sample retrieval and shipping within 24 hours upon request.
- Adherence to Good Laboratory Practices (GLP) and handling of cellular and gene therapy materials, enabling researchers to reclaim valuable lab space and scientist time.

• - Proactive Asset Management (PAM) serves organizations with concluded studies where samples are still scattered across various locations. Resonant plays a crucial role in consolidating these samples, liaising with partner labs and CROs, and ensuring a streamlined transfer process to its secure long-term biobank. This includes generating validated inventory lists for audits and future study planning.

• - Strategic Asset Management (SAM) is for organizations considering a shift in their storage strategies. This program involves analyzing the costs associated with current inventory and storage solutions, evaluating the fiscal and operational impact of transferring samples, and determining the best strategic approach moving forward.

As emphasized by Corey Stone, Vice President and General Manager of Biorepository at Resonant Clinical Solutions, "We’ve designed these programs to cater precisely to our clients’ diverse needs… from reliable operation to efficient cost management, these solutions are geared towards adding true value."

With the entire suite available immediately, Resonant Clinical Solutions aims to alleviate the burdens faced by organizations in the life sciences sector, allowing them to concentrate on what matters most: the advancement of scientific research and improving patient outcomes. For further details, visit resonantclinical.com/sample-asset-management or reach out directly to their team.

Amidst the complexities of modern clinical trials, such innovative solutions will undoubtedly play a significant role in streamlining the intricate processes involved in sample management and biobanking.

About Resonant Clinical Solutions

Founded as a comprehensive partner for clinical solutions, Resonant supports life sciences organizations throughout the entire clinical supply chain and the sample lifecycle. With a mission to simplify complex processes and enable a focus on scientific and patient-driven outcomes, the company manages more than 100 million research resources and has orchestrated over 20,000 shipments to client sites globally. For more information about Resonant Clinical Solutions, visit their official website.